Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B vitamins added to Humira for plaque psoriasis
NCT01704599Phase 2Terminated
- Sponsor
- Wayne State University
- Start
- Jan 2009
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 2, open-label trial of pyridoxine, folic acid and cyanocobalamin in plaque psoriasis, sponsored by Wayne State University. Primary endpoint: Psoriasis Area and Severity Index at 28 weeks. Started Jan 2009; status: terminated.
02
Drugs
pyridoxinefolic acidcyanocobalamin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01704599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704599.